Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on hemostatic variables in men

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 3, 1996, Pages 375-380

  Almendingen, Kari ^a   Seljeflot, Ingebjørg ^b   Sandstad, Berit ^a   Pedersen, Jan I ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Akershus College   (Norway)

Author keywords

coagulation; diet; fibrinolysis; hydrogenation; trans fatty acids

Indexed keywords

BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; FIBRINOLYTIC AGENT; FIBRINOPEPTIDE A; FISH OIL; LIPOPROTEIN A; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROCOAGULANT; SOYBEAN OIL; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOTTING; BUTTER; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FAT INTAKE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYDROGENATION; LIPID COMPOSITION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029927930     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.3.375     Document Type: Article

References (59)

1. Hamsten A, Blombäck M, Wiman B, Svensson J, Szamosi A, de Faire U, Mettinger L. Haemostatic function in myocardial infarction. Br Heart J. 1986;55:58-66.
2. Smith EB. Fibrinogen, fibrin and fibrin degradation productions in relation to atherosclerosis. Clin Hematol. 1986;15:355-370.
3. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 1991;91:191-205.
4. Ridker PM. An epidemiologic assessment of thrombotic risk factors for cardiovascular disease. Curr Opin Lipidol. 1992;3:285-290.
5. Kannel WB, Wolf PA, Castelli WP, D'Agostino RP. Fibrinogen and risk of cardiovascular disease: the Framingham study. JAMA. 1987;258:1183-1186.
6. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993;118:956-963.
7. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart study. Lancet. 1986;2:533-537.
8. Hamsten A, Wiman B, de Faire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med. 1985;313:1557-1563.
9. Juhan-Vague I, Alessi MC. Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost. 1993;70:138-143.
10. Jansson JH, Nilsson TK, Olofsson BO. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur Heart J. 1991;12:157-161.
11. Zysow BR, Lawn RM. The relationship of lipoprotein(a) to hemostasis. Curr Opin Lipidol. 1993;4:484-489.
12. Dahlen GH. Lp(a) lipoprotein in cardiovascular disease: review article and viewpoint. Atherosclerosis. 1994;108:111-126.
13. Miller GJ, Martin JC, Webster J, Wilkes H, Miller NE, Wilkinson WH, Meade TW. Association between dietary fat intake and plasma factor VII coagulant activity: a predictor of cardiovascular mortality. Atherosclerosis. 1986;60:269-277.
14. Marckmann P, Sandstrøm BM, Jespersen J. Low-fat high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr. 1994;59:935-939.
15. Marckmann P, Sandström BM, Jespersen J. Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb. 1993;13:505-511.
16. Marckmann P, Sandström BM, Jespersen J. Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in dietary fat content. Arterioscler Thromb. 1992;12:201-205.
17. Marckmann P, Sandström BM, Jespersen J. Dietary effects on circadian fluctation in human blood coagulation factor VII and fibrinolysis. Atherosclerosis. 1993;101:225-234.
18. Mehrabian M, Peter JB, Barnard RJ, Lusis AJ. Dietary regulation of fibrinolytic factors. Atherosclerosis. 1990;84:25-32.
19. Marckmann P, Sandström B, Jespersen J. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis. 1990;80:227-233.
20. Miller GJ, Martin JC, Mitropoulos KA, Reeves BEA, Thompson RL, Meade TW, Cooper JA, Cruickshank JK. Plasma factor VII is activated by postprandial triglyceridemia, irrespective of dietary fat composition. Atherosclerosis, 1991;86:163-171.
21. Mitropoulos KA, Miller GJ, Martin JC, Reeves BEA, Cooper J. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb. 1994;14:214-222.
22. Tholstrup T, Marckmann P, Jespersen J, Sandström BM. Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic acid and lauric acid. Am J Clin Nutr. 1994;59:371-377.
23. Dietary trans-Unsaturated Fatty Acids and Cardiovascular Disease, Hertfordshire, UK: Association of Fish Meal Manufacturers; 1986.
24. Enig MG. trans-Fatty Acids in the Food Supply: A Comprehensive Report Covering 60 Years of Research. Silver Spring, Md: Enig Associates Inc; 1993.
25. Ackman RG. Composition of fish oils. In: Barlow SM, Stansby ME, eds. Nutritional Evaluation of Long-Chain Fatty Acids in Fish Oil. London, UK: Academic Press; 1982:25-88.
26. Mensink RP, Katan MB. Trans monounsaturated fatty acids in nutrition and their impact on serum lipoprotein levels in man. J Lipid Res. 1993;32:111-122.
27. Almendingen K, Jordal O, Kierulf P, Sandstad B, Pedersen JI. Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp(a) in men. J Lipid Res. 1995;36:1370-1384.
28. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med. 1990;323:439-445.
29. Nestel P, Noakes M, Belling B, McArthur R, Clifton P, Janus E, Abbey M. Plasma lipoprotein lipid and Lp(a) changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res. 1992;33:1029-1036.
30. Lichtenstein AH, Ausman LM, Carrasco W, Jenner JL, Ordovas J, Schaefer EJ. Hydrogenation impairs the hypolipidemic effect of corn oil in humans: hydrogenation, trans-fatty acids, and plasma lipids. Arterioscler Thromb. 1993;13:154-161.
31. Wood R, Kubena K, O'Brian B, Tseng S, Martin G. Effect of butter, mono- and polyunsaturated fatty acid-enriched butter, trans fatty acid margarine, and zero trans fatty acid margarine on serum lipids and lipoproteins in healthy men. J Lipid Res. 1993;34:1-11.
32. Zock PL, Katan MB. Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res, 1992;33:399-410.
33. Judd JT, Clevidence BA, Muesing RA, Wittes J, Sunkin ME, Podczasy JJ. Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr. 1994;59:861-868.
34. Mensink RP, Zock PL, Katan MB, Hornstra G. Effect of dietary cis and trans fatty acids on serum lipoprotein(a) levels in humans. J Lipid Res, 1992;33:1493-1501.
35. Ascherio A, Hennekens CH, Buring JE, Mater C, Stampfer MJ, Willett W. trans-Fatty acids intake and risk of myocardial infarction. Circulation. 1994;89:94-101.
36. Siguel EN, Lerman LH. trans-Fatty acid patterns in patients with angiographically documented coronary heart disease. Am J Cardiol. 1993;71:916-920.
37. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, Sampson LA, Hennekens CH. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993;341:581-585.
38. Troisi R, Willett WC, Weiss ST. trans-Fatty acid intake in relation to serum lipid concentrations in adult men. Am J Clin Nutr. 1992;56:1019-1024.
39. Rosenthal MD, Doloresco MA. The effects of trans fatty acids on fatty acyl delta 5 desaturation by human skin fibroblasts. Lipids. 1984;19:869-874.
40. Decsi T, Koletzko B. Do trans fatty acids impair linoleic acid metabolism in children? Ann Nutr Metab. 1995;39:36-41.
41. Wahle KWJ, James WPT. Isomeric fatty acids and human health. Eur J Clin Nutr. 1993;47:828-839.
42. Marckmann P, Jespersen J, Leth T, Sandström BM. Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. J Intern Med. 1991;229:317-323.
43. Emeis JJ, van Houwelingen AC, van den Hoogen CM, Hornstra G. A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. Blood. 1989;74:233-237.
44. Chmielewska J, Rånby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res. 1983;31:427-436.
45. Clauss A. Gerinnungsphysiologische schnellmetode zur bestimmung des fibrinogens. Acta Haematol. 1957;17:237-246.
46. Nossel HL, Yudelman I, Canfield RE, Butler VP, Spanondis K, Wilner GD, Qureshi GD. Measurement of fibrinopeptide A (FPA) in human blood. J Clin Invest. 1974;54:43-53.
47. Skjønsberg OH, Kierulf P, Fagerhol MK, Godal HC. Thrombin generation during collection and storage of blood. Vox Sang. 1986;50:33-37.
48. Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariable Methods. 2nd ed. Boston, Mass: PWS-KENT Publishing Co; 1988.
49. Conover WJ. Practical Nonparametric Statistics, 2nd ed. New York, NY: John Wiley & Sons Inc; 1980:295-299.
50. Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism. 1986;35:250-253.
51. Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L, Smith U. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism. 1990;39:1044-1048.
52. Hjermann I. The influence of dietary change on hemostatic risk variables. Ann Epidemiol. 1992;2:525-527.
53. Andersen P, Nilsen DWT, Beckmann SL, Holme I, Hjermann I. Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals. Acta Med Scand. 1988;22:499-506.
54. Folsom AR, Qamhieh HT, Wing RR, Jeffery RW, Stinson VL, Kuller LH, Wu KK. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb. 1993;13:162-169.
55. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-1209.
56. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood OC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;334:757-761.
57. Kariko K, Rosenbaum H, Kuo A, Zurier RB, Barnathan ES. Stimulatory effect of unsaturated fatty acids on the level of plasminogen activator inhibitor-1 mRNA in culturated human endothelial cells. FEBS Lett. 1995;361:118-122.
58. Bladberg EM, Tholstrup T, Marckmann P, Sandström BM, Jespersen J. Dietary changes in fasting levels of factor VII coagulant activity (FVII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteins. Thromb Haemost. 1995;73:239-242.
59. Halvorsen S, Skjønsberg OH, Berg K, Ruyter R, Godal HC. Does Lp(a) inhibit the fibrinolytic system? Thromb Res. 1992;68:223-232.